Trial
NCT01692626
1% Topical Pimecrolimus Cream for the Treatment of the Rash Associated With ERBITUX
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
West Virginia University
Collaborators
—
Condition
Rash
Intervention
Pimecrolimus
Why stopped
Interim analysis shows no efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-15